CHEK2 and breast cancer: Because CHEK2*1100delC mice have indolent tumorigenesis and only a small proportion present with mammary tumors, we next examined evolution of preneoplastic lesions in a mammary tumor susceptible transgenic mouse model (MMTV-Ron kinase) crossed into the CHEK2*1100delC line (42).